Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This mechanistic study is designed to investigate the effect of vildagliptin on the
sensitivity of the a-cell to glucose under hypoglycemic conditions in patients with type 2
diabetes (T2DM).